 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from scanned originals with text recognition applied 
(searchable text may contain so me errors and/or omissions) 
 
 
1 
2 Date: 51\S I\ '1 MAJORITY L.D. 1047 
(Filing No. S-\ O\.Q.) 
3 HEAL TH COVERAGE, INSURANCE AND FINANCIAL SERVICES 
4 Reproduced and distributed under the direction of the Secretary of the Senate. 
5 STATE OF MAINE 
6 SENATE 
7 129TH LEGISLATURE 
8 FIRST REGULAR SESSION 
9 COMMITTEE AMENDMENT "/t " to S.P. 307, L.D. 1047, Bill, "An Act To 
10 Prohibit Consideration ofNaloxone Purchases in Life Insurance Underwriting" 
11 Amend the bill by striking out all of section 1 and inserting the following: 
12 'Sec. 1. 24-A MRSA ยง2159-E is enacted to read: 
13 ยง2159-E. Discrimination against naloxone hydrochloride purchases prohibited in 
14 life insurance 
15 1. Discrimination prohibited. Notwithstanding any provision oflaw to the contrary 
16 and except as provided in subsection 2. an insurer authorized to do business in this State 
17 may not: 
18 A. Limit coverage or refuse to issue or renew coverage of an individual under any 
19 life insurance policy due to the fact that the individual has been issued a prescription 
20 for naloxone hydrochloride or has purchased naloxone hydrochloride in accordance 
21 with Title 22. section 2353; 
22 B. Consider the fact that an individual has been issued a prescription for naloxone 
23 hydrochloride or has purchased naloxone hydrochloride in determining the premium 
24 rate for coverage of that individual under a life insurance policy; or 
25 C. Otherwise discriminate in the offering. issuance, cancellation, amount of 
26 coverage. price or any other condition of a life insurance policy based solely and 
27 without any additional actuarial justification upon the fact that an individual has been 
28 issued a prescription for naloxone hydrochloride or has purchased naloxone 
29 hydrochloride. 
30 2. Exception. An insurer may take an action described in subsection 1 with respect 
31 to an individual who has a demonstrated history of opioid use disorder.' 
32 Amend the bill by relettering or renumbering any nonconsecutive Part letter or 
33 section number to read consecutively. 
Page 1 -129LR1919(02)-1 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "A "to S.P. 307, L.D. 1047 ( S-\ <.:)\.o=) 
I SUMMARY 
2 This amendment is the majority report and replaces the bill. The amendment 
3 prohibits a denial or limitation of coverage or an increase in insurance premiums under a 
4 life insurance policy based on the fact that an individual has been issued a prescription for 
5 naloxone hydrochloride or has purchased naloxone hydrochloride. The amendment also 
6 provides an exception to the prohibition when the individual has a demonstrated history 
7 of opioid use disorder. 
Page 2 -129LR1919(02)-1 
COMMITTEE AMENDMENT 
